BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang YZ, Li JL, Wang X, Zhang T, Ho WZ. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes. World J Gastroenterol 2017; 23(32): 5895-5903 [PMID: 28932081 DOI: 10.3748/wjg.v23.i32.5895]
URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5895.htm
Number Citing Articles
1
Lucia Capasso, Luigi De Masi, Carmina Sirignano, Viviana Maresca, Adriana Basile, Angela Nebbioso, Daniela Rigano, Paola Bontempo. Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic PotentialMolecules 2025; 30(3): 654 doi: 10.3390/molecules30030654
2
Jiaming Ge, Tianbao Song, Mengyuan Li, Weisan Chen, Jiarong Li, Sihan Gong, Ying Zhao, Lin Ma, Hongjian Yu, Xiankuan Li, Kun Fu. The medicinal value of tea drinking in the management of COVID-19Heliyon 2023; 9(1): e12968 doi: 10.1016/j.heliyon.2023.e12968
3
Yan-Xi Zeng, Sen Wang, Lu Wei, Ying-Yu Cui, Yi-Han Chen. Proanthocyanidins: Components, Pharmacokinetics and Biomedical PropertiesThe American Journal of Chinese Medicine 2020; 48(04): 813 doi: 10.1142/S0192415X2050041X
4
Zhaodi Zheng, Junying Gao, Yubing Ma, Xitan Hou. Cellular and Molecular Mechanisms of Phytochemicals Against Inflammation‐Associated Diseases and Viral InfectionCell Biology International 2025;  doi: 10.1002/cbin.70011
5
Dongming Li, Donghui Cao, Yingnan Cui, Yuanlin Sun, Jing Jiang, Xueyuan Cao. The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinomaFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1201085
6
Naiara Naiana Dejani, Hatem A. Elshabrawy, Carlos da Silva Maia Bezerra Filho, Damião Pergentino de Sousa. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic PerspectivesBiomolecules 2021; 11(8): 1254 doi: 10.3390/biom11081254